Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

NCT00527605 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

253

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia
Prostatic Hyperplasia

Interventions

DRUG: Dutasteride 0.5mg capsule
DRUG: Dutasteride matched placebo

Sponsor

GlaxoSmithKline